SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-016274
Filing Date
2021-01-25
Accepted
2021-01-25 16:30:28
Documents
6
Effectiveness Date
2021-01-25

Document Format Files

Seq Description Document Type Size
1 S-8 d78054ds8.htm S-8 76154
2 EX-5.1 d78054dex51.htm EX-5.1 8862
3 EX-23.1 d78054dex231.htm EX-23.1 4537
4 EX-23.2 d78054dex232.htm EX-23.2 1506
5 GRAPHIC g78054e1.jpg GRAPHIC 9069
6 GRAPHIC g78054s4.jpg GRAPHIC 10415
  Complete submission text file 0001193125-21-016274.txt   108518
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-252396 | Film No.: 21549944
SIC: 2834 Pharmaceutical Preparations